Determination of minimum bactericidal concentration, in single or combination drugs, against Mycobacterium tuberculosis

To evaluate an assay to detect minimum bactericidal concentration (MBC) in , using as single model rifampicin, isoniazid, levofloxacin (LVX) and linezolid (LNZ) and in combination. MBCs were carried out directly from resazurin microtiter assay plate and 3D checkerboard in H Rv and five resistant cli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future microbiology 2020-01, Vol.15 (2), p.107-114
Hauptverfasser: Santos, Nathally C de S, Scodro, Regiane B de L, Leal, Dayane Cb, do Prado, Silvia Mt, Micheletti, Daniela F, Sampiron, Eloísa G, Costacurta, Giovana F, de Almeida, Aryadne L, da Silva, Liliani Af, Ieque, Andressa L, Ghiraldi Lopes, Luciana D, de Pádua, Rubia Af, Siqueira, Vera Ld, Caleffi-Ferracioli, Katiany R, Cardoso, Rosilene F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate an assay to detect minimum bactericidal concentration (MBC) in , using as single model rifampicin, isoniazid, levofloxacin (LVX) and linezolid (LNZ) and in combination. MBCs were carried out directly from resazurin microtiter assay plate and 3D checkerboard in H Rv and five resistant clinical isolates. The proposed MBC assay showed similar values to those determined by MGIT™, used as control. LVX and LNZ's MBC values were close to their MIC values. LNZ or LVX combined with isoniazid and rifampicin showed MBC value reduced in 63.7% of the assays. The proposed assay to determine MBCs of drugs can be applied to the study of new compounds with anti- activity to detect their bactericidal effect and also in laboratory routine for clinical dose adjustment of drugs according to the patient's profile.
ISSN:1746-0913
1746-0921
DOI:10.2217/fmb-2019-0050